Use of intermittent or continuous interstitial fluid glucose monitoring in patients with diabetes mellitus.
D001786:Blood Glucose / Q000032:analysis*; D015190:Blood Glucose Self-Monitoring / Q000379:methods*; D054598:Blue Cross Blue Shield Insurance Plans; D018795:Device Approval; D003920:Diabetes Mellitus / Q000628:therapy; D005069:Evaluation Studies as Topic; D045604:Extracellular Fluid / Q000737:chemistry; D006801:Humans; D019458:Insurance Coverage; D017063:Outcome Assessment, Health Care; D015203:Reproducibility of Results; D013673:Technology Assessment, Biomedical; D014481:United States; D014486:United States Food and Drug Administration
D001786:Blood Glucose